Please assess the completion status of the following clinical trial:

Trial Title: Debritom - Micro Water Jet Technology and Wound Healing

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Male or female age 18 or older~* The ability and willingness to provide Informed consent~* Presence of a chronic lower extremity ulcer~* Chronic ulcer is defined as that greater than 4 weeks in duration.~* Subject's informed consent for participation prior to proceeding with micro water jet technology debridement~* Patient's ulcer cannot exhibit any gross clinical signs of infection.~* Patient is willing to participate in all procedures and follow up evaluations necessary to complete the study.~* Patient willing and able to comply with having micro water jet technology debridement potentially weekly or biweekly as part of their wound care treatment plan for up to 20 weeks.~Exclusion Criteria:~* Patients with active wound infection, or untreated osteomyelitis~* Patients with dementia, or impaired cognitive function~* Patients who are unable or unwilling to participate in all procedures and follow up evaluations~* Patient has Active Charcot foot~* Patient with malignant wounds

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Micro Water Jet Technology (Debritom) (Type: OTHER): Debritom is a hydrosurgery device that utilizes micro water jet technology that has been designed to debride acute and chronic wounds precisely and in a tissue-preserving manner.~All subject will get the Debritom.

Based on this trial design, predict the completion outcome and termination type (if applicable).